These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 28926130)

  • 1. Clostridium difficile infection in intestinal transplant recipients.
    Goldenberg V; Berbel A; Camargo JF; Simkins J
    Transpl Int; 2018 Jan; 31(1):116-117. PubMed ID: 28926130
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention and medical management of Clostridium difficile infection.
    Shannon-Lowe J; Matheson NJ; Cooke FJ; Aliyu SH
    BMJ; 2010 Mar; 340():c1296. PubMed ID: 20228142
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk factors for Clostridium difficile infection in intestinal transplant recipients during the first year post-transplant.
    Guzman L; Qiu F; Kalil AC; Mercer DF; Langnas A; Florescu DF
    Transpl Infect Dis; 2018 Apr; 20(2):e12858. PubMed ID: 29427406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospital-acquired Clostridium difficile infection among patients with type 2 diabetes mellitus in acute medical wards.
    Hassan SA; Rahman RA; Huda N; Wan Bebakar WM; Lee YY
    J R Coll Physicians Edinb; 2013; 43(2):103-7. PubMed ID: 23734349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridium difficile infection and colonization.
    Lapane KL; Motzkus-Feagans C; Pakyz A
    N Engl J Med; 2012 Jan; 366(3):276; author reply 276-7. PubMed ID: 22256813
    [No Abstract]   [Full Text] [Related]  

  • 6. Host and pathogen factors for Clostridium difficile infection and colonization.
    Loo VG; Bourgault AM; Poirier L; Lamothe F; Michaud S; Turgeon N; Toye B; Beaudoin A; Frost EH; Gilca R; Brassard P; Dendukuri N; Béliveau C; Oughton M; Brukner I; Dascal A
    N Engl J Med; 2011 Nov; 365(18):1693-703. PubMed ID: 22047560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridium difficile infection and proton pump inhibitors.
    Pohl JF
    Curr Opin Pediatr; 2012 Oct; 24(5):627-31. PubMed ID: 22781139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton Pump Inhibitors Should be Used with Caution in Critically Ill Patients to Prevent the Risk of Clostridium difficile Infection.
    Min JH; Kim YS
    Gut Liver; 2016 Jul; 10(4):493-4. PubMed ID: 27377737
    [No Abstract]   [Full Text] [Related]  

  • 9. Proton pump inhibitors and diarrhoea related to Clostridium difficile infection in hospitalised patients: a case-control study.
    Leonard AD; Ho KM; Flexman J
    Intern Med J; 2012 May; 42(5):591-4. PubMed ID: 22616966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients.
    Barletta JF; Sclar DA
    Crit Care; 2014 Dec; 18(6):714. PubMed ID: 25540023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium difficile.
    Baierlein SA; Wistop A
    N Engl J Med; 2009 Feb; 360(6):636-7; author reply 637-8. PubMed ID: 19202581
    [No Abstract]   [Full Text] [Related]  

  • 12. Proton Pump Inhibitors and the Risk for Hospital-Acquired Clostridium difficile Infection.
    Barletta JF; El-Ibiary SY; Davis LE; Nguyen B; Raney CR
    Mayo Clin Proc; 2013 Oct; 88(10):1085-90. PubMed ID: 24012413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of Clostridium difficile infection in patients receiving high-risk antibiotics with or without a proton pump inhibitor.
    Gordon D; Young LR; Reddy S; Bergman C; Young JD
    J Hosp Infect; 2016 Feb; 92(2):173-7. PubMed ID: 26616410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continued high use of PPIs despite C. difficile risk.
    Brown C
    CMAJ; 2014 Dec; 186(18):1350. PubMed ID: 25384647
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk of Clostridium difficile Infection with the Use of a Proton Pump Inhibitor for Stress Ulcer Prophylaxis in Critically Ill Patients.
    Ro Y; Eun CS; Kim HS; Kim JY; Byun YJ; Yoo KS; Han DS
    Gut Liver; 2016 Jul; 10(4):581-6. PubMed ID: 27021503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton pump inhibitors and risk for recurrent Clostridium difficile infection.
    Linsky A; Gupta K; Lawler EV; Fonda JR; Hermos JA
    Arch Intern Med; 2010 May; 170(9):772-8. PubMed ID: 20458084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton pump inhibitors and the risk for Clostridium difficile infection.
    Famularo G; Gasbarrone L; De Simone C
    JAMA; 2009 Jul; 302(1):31-2; author reply 32. PubMed ID: 19567433
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of Acid Suppression Medication is Associated With Risk for C. difficile Infection in Infants and Children: A Population-based Study.
    Freedberg DE; Lamousé-Smith ES; Lightdale JR; Jin Z; Yang YX; Abrams JA
    Clin Infect Dis; 2015 Sep; 61(6):912-7. PubMed ID: 26060292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infection in solid-organ transplant recipients.
    Cross TJ; Berry PA; Burroughs AK
    N Engl J Med; 2008 Mar; 358(12):1302. PubMed ID: 18354113
    [No Abstract]   [Full Text] [Related]  

  • 20. Fidaxomicin for Clostridium difficile infection.
    Linsky A; Gupta K; Hermos JA
    N Engl J Med; 2011 May; 364(19):1875; author reply 1875-6. PubMed ID: 21561361
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.